Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
Philips (NYSE: PHG) and Masimo (NASDAQ: MASI) have announced a renewed multi-year strategic partnership focused on advancing patient monitoring technologies. The collaboration will integrate Masimo's advanced monitoring technologies, including SET® pulse oximetry, Radius PPG, and sensor technology, into Philips' multi-parameter patient monitoring platforms.
The partnership aims to develop and co-promote next-generation monitoring solutions, with a focus on patient mobility, AI algorithms, and smart connected care. The integration will support clinicians with reliable data and actionable insights across bedside monitors, central stations, and wearable solutions within a unified system.
Philips (NYSE: PHG) e Masimo (NASDAQ: MASI) hanno annunciato un rinnovo della partnership strategica pluriennale volta a potenziare le tecnologie di monitoraggio dei pazienti. La collaborazione prevede l’integrazione delle avanzate soluzioni Masimo, incluse SET® pulse oximetry, Radius PPG e le tecnologie dei sensori, nelle piattaforme multiparametriche di monitoraggio di Philips.
L’intesa mira a sviluppare e promuovere congiuntamente soluzioni di monitoraggio di nuova generazione, con particolare attenzione alla mobilità del paziente, agli algoritmi di intelligenza artificiale e all’assistenza connessa intelligente. L’integrazione offrirà ai clinici dati affidabili e informazioni utilizzabili su monitor a lato letto, stazioni centrali e dispositivi indossabili all’interno di un sistema unificato.
Philips (NYSE: PHG) y Masimo (NASDAQ: MASI) han anunciado la renovación de una asociación estratégica plurianual centrada en mejorar las tecnologías de monitorización de pacientes. La colaboración integrará las avanzadas tecnologías de Masimo, incluida la oximetría de pulso SET®, Radius PPG y la tecnología de sensores, en las plataformas multiparámetro de monitorización de Philips.
La alianza busca desarrollar y co-promocionar soluciones de monitorización de nueva generación, con énfasis en la movilidad del paciente, los algoritmos de IA y la atención inteligente conectada. La integración apoyará a los clínicos con datos fiables e información accionable a través de monitores de cabecera, estaciones centrales y soluciones portátiles dentro de un sistema unificado.
Philips (NYSE: PHG)와 Masimo (NASDAQ: MASI)는 환자 모니터링 기술 발전을 목표로 한 다년 전략적 파트너십을 갱신했다고 발표했습니다. 이 협력으로 Masimo의 고급 모니터링 기술, 포함하여 SET® 맥박 산소측정(pulse oximetry), Radius PPG 및 센서 기술이 Philips의 다중 매개변수 환자 모니터링 플랫폼에 통합됩니다.
이번 파트너십은 환자 이동성, AI 알고리즘 및 스마트 연결 케어에 초점을 맞춘 차세대 모니터링 솔루션을 개발하고 공동으로 홍보하는 것을 목표로 합니다. 통합된 시스템 내에서 침상 모니터, 중앙 스테이션 및 웨어러블 솔루션 전반에 걸쳐 임상의에게 신뢰할 수 있는 데이터와 실용적인 인사이트를 제공할 것입니다.
Philips (NYSE: PHG) et Masimo (NASDAQ: MASI) ont annoncé le renouvellement d’un partenariat stratégique pluriannuel visant à faire progresser les technologies de surveillance des patients. La collaboration intégrera les technologies avancées de Masimo, notamment la oxymétrie de pouls SET®, Radius PPG et la technologie des capteurs, aux plateformes de surveillance multiparamétriques de Philips.
Le partenariat a pour objectif de développer et de co-promouvoir des solutions de surveillance de nouvelle génération, en mettant l’accent sur la mobilité des patients, les algorithmes d’IA et les soins connectés intelligents. L’intégration fournira aux cliniciens des données fiables et des informations exploitables sur les moniteurs au chevet, les stations centrales et les solutions portables au sein d’un système unifié.
Philips (NYSE: PHG) und Masimo (NASDAQ: MASI) haben eine erneuerte mehrjährige strategische Partnerschaft angekündigt, die auf die Weiterentwicklung der Patientenüberwachung abzielt. Die Zusammenarbeit wird Masimos fortschrittliche Überwachungstechnologien, darunter SET® Pulsoximetrie, Radius PPG und Sensortechnologie, in Philips’ multiparametrische Patientenüberwachungsplattformen integrieren.
Ziel der Partnerschaft ist die Entwicklung und gemeinsame Vermarktung von Monitorlösungen der nächsten Generation, mit Fokus auf Patientenmobilität, KI-Algorithmen und intelligente vernetzte Versorgung. Die Integration wird Kliniker mit verlässlichen Daten und verwertbaren Erkenntnissen über Raumgeräte, Zentraleinheiten und tragbare Lösungen innerhalb eines einheitlichen Systems unterstützen.
- Integration of Masimo's advanced monitoring technologies into Philips' platforms enhances system capabilities
- Partnership focuses on developing AI algorithms and next-generation monitoring solutions
- Collaboration aims to reduce complexity and enhance interoperability in healthcare systems
- Agreement supports expansion of smart, connected care solutions
- None.
Insights
Philips-Masimo partnership integrates advanced monitoring technologies to enhance clinical decision-making and patient care continuity across healthcare settings.
Philips and Masimo have renewed their multi-year strategic collaboration with an expanded focus on integrating Masimo's specialized monitoring technologies into Philips' patient monitoring platforms. This partnership combines Masimo's SET® pulse oximetry, Radius PPG, and sensor technologies with Philips' comprehensive monitoring ecosystem.
The integration creates a unified monitoring system that allows clinicians to access their preferred measurement technologies across bedside monitors, central stations, and wearable solutions. This addresses a critical pain point in healthcare settings where fragmented monitoring systems often create operational inefficiencies and data silos.
The partnership's strategic value extends beyond current product integration. Both companies have committed to co-developing next-generation monitoring solutions that respond to emerging clinical needs, particularly around patient mobility. Their roadmap appears to include AI algorithm development that could enhance predictive capabilities and clinical decision support.
For Philips, this partnership aligns with their broader strategy of enabling vendor-neutral interoperability while maintaining their position in the patient monitoring ecosystem. For Masimo, the collaboration provides expanded market access for their measurement technologies through Philips' established global distribution channels.
This renewal suggests previous collaboration phases have been successful, with both companies recognizing mutual value in combining Masimo's specialized measurement expertise with Philips' integrated monitoring platforms. The emphasis on interoperability reflects healthcare's ongoing shift toward more connected and flexible monitoring solutions that can operate across various care settings.
September 11, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. With a shared commitment to innovation and expanding access to high-quality, connected care, the two companies are taking a bold new approach in accelerating the development and delivery of next-generation patient monitoring solutions. This expanded agreement reflects our commitment to empower clinicians with smarter, more integrated technologies that support better outcomes across the continuum of care.
Accelerating access to next-generation monitoring technologies
At the heart of the expanded partnership is a joint effort to integrate Masimo’s advanced monitoring technologies – including SET® pulse oximetry, Radius PPG, and a range of sensor technology – into Philips’ multi-parameter patient monitoring platforms. This integration supports clinicians with reliable data and actionable insights across bedside monitors, central stations, and wearable solutions, while giving them the flexibility to use their preferred measurement technologies within a single, unified system. By embedding these capabilities into Philips’ monitoring ecosystem, the collaboration aims to reduce complexity, enhance interoperability, and deliver streamlined tools that support timely decision-making and continuity of care.
Building on this foundation, Philips and Masimo also plan to collaborate on the development and co-promotion of next-generation monitoring solutions that reflect emerging clinical needs and evolving market demands such as the need for greater patient mobility. These efforts are focused on advancing smart, connected care and expanding access to innovative technologies, including AI algorithms, that have the potential to improve patient care over time.
“Our priority is helping clinicians deliver the best possible care to their patients, and that means staying ahead of the curve,” said Julia Strandberg, Executive Vice President and Business Leader Connected Care at Royal Philips. “This partnership allows us to respond quickly to evolving clinical needs and market trends, integrating proven technologies into solutions that are easy to use, reliable, and scalable.”
“We are excited to continue to partner with Philips to bring Masimo’s newest innovations in wearables and artificial intelligence to Philips’ platforms,” said Katie Szyman, CEO of Masimo. “Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients. Together, Masimo and Philips will continue to empower clinicians to transform patient care.”
A shared commitment to innovation and impact
The renewed partnership underscores both companies’ dedication to transforming patient care through meaningful innovation. By bringing together Philips’ deep expertise in patient monitoring and Masimo’s advanced noninvasive technologies, the collaboration is focused on delivering integrated, clinically validated solutions that scale to meet the needs of healthcare providers. It also aligns with Philips’ broader strategy to work with industry-leading partners to enhance care delivery, improve operational efficiency, and support vendor-neutral interoperability across healthcare systems.
For further information, please contact:
Mark Groves
External Relations, Philips
Tel: +31 631 639 916
E-mail: mark.groves@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment
FAQ
What technologies will be integrated into Philips' monitoring platforms through the Masimo partnership?
How will the Philips-Masimo partnership benefit healthcare providers?
What are the main focus areas of the Philips-Masimo strategic collaboration?
Who are the key executives involved in the Philips-Masimo partnership?
What is the duration of the Philips-Masimo partnership agreement?
